These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

482 related items for PubMed ID: 2536059

  • 1. T lymphocyte cytotoxicity with natural varicella-zoster virus infection and after immunization with live attenuated varicella vaccine.
    Diaz PS, Smith S, Hunter E, Arvin AM.
    J Immunol; 1989 Jan 15; 142(2):636-41. PubMed ID: 2536059
    [Abstract] [Full Text] [Related]

  • 2. Equivalent recognition of a varicella-zoster virus immediate early protein (IE62) and glycoprotein I by cytotoxic T lymphocytes of either CD4+ or CD8+ phenotype.
    Arvin AM, Sharp M, Smith S, Koropchak CM, Diaz PS, Kinchington P, Ruyechan W, Hay J.
    J Immunol; 1991 Jan 01; 146(1):257-64. PubMed ID: 1670603
    [Abstract] [Full Text] [Related]

  • 3. Recognition of the latency-associated immediate early protein IE63 of varicella-zoster virus by human memory T lymphocytes.
    Sadzot-Delvaux C, Kinchington PR, Debrus S, Rentier B, Arvin AM.
    J Immunol; 1997 Sep 15; 159(6):2802-6. PubMed ID: 9300702
    [Abstract] [Full Text] [Related]

  • 4. Herpes simplex virus-specific human cytotoxic T-cell colonies expressing either gamma delta or alpha beta T-cell receptor: role of accessory molecules on HLA-unrestricted killing of virus-infected targets.
    Maccario R, Comoli P, Percivalle E, Montagna D, Locatelli F, Gerna G.
    Immunology; 1995 May 15; 85(1):49-56. PubMed ID: 7635521
    [Abstract] [Full Text] [Related]

  • 5. Comparison of primary sensitization of naive human T cells to varicella-zoster virus peptides by dendritic cells in vitro with responses elicited in vivo by varicella vaccination.
    Jenkins DE, Yasukawa LL, Bergen R, Benike C, Engleman EG, Arvin AM.
    J Immunol; 1999 Jan 01; 162(1):560-7. PubMed ID: 9886433
    [Abstract] [Full Text] [Related]

  • 6. Human ocular-derived virus-specific CD4+ T cells control varicella zoster virus replication in human retinal pigment epithelial cells.
    Milikan JC, Baarsma GS, Kuijpers RW, Osterhaus AD, Verjans GM.
    Invest Ophthalmol Vis Sci; 2009 Feb 01; 50(2):743-51. PubMed ID: 18936136
    [Abstract] [Full Text] [Related]

  • 7. Cell-mediated immunity to varicella-zoster virus.
    Arvin AM.
    J Infect Dis; 1992 Aug 01; 166 Suppl 1():S35-41. PubMed ID: 1320649
    [Abstract] [Full Text] [Related]

  • 8. Immunogenicity of a two-dose regime of varicella vaccine in children with cancers.
    Leung TF, Li CK, Hung EC, Chan PK, Mo CW, Wong RP, Chik KW.
    Eur J Haematol; 2004 May 01; 72(5):353-7. PubMed ID: 15059071
    [Abstract] [Full Text] [Related]

  • 9. Demonstration of NK cell-mediated lysis of varicella-zoster virus (VZV)-infected cells: characterization of the effector cells.
    Tilden AB, Cauda R, Grossi CE, Balch CM, Lakeman AD, Whitley RJ.
    J Immunol; 1986 Jun 01; 136(11):4243-8. PubMed ID: 3009620
    [Abstract] [Full Text] [Related]

  • 10. Identification of viral antigens recognized by ocular infiltrating T cells from patients with varicella zoster virus-induced uveitis.
    Milikan JC, Kinchington PR, Baarsma GS, Kuijpers RW, Osterhaus AD, Verjans GM.
    Invest Ophthalmol Vis Sci; 2007 Aug 01; 48(8):3689-97. PubMed ID: 17652740
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine.
    Levin MJ, Smith JG, Kaufhold RM, Barber D, Hayward AR, Chan CY, Chan IS, Li DJ, Wang W, Keller PM, Shaw A, Silber JL, Schlienger K, Chalikonda I, Vessey SJ, Caulfield MJ.
    J Infect Dis; 2003 Nov 01; 188(9):1336-44. PubMed ID: 14593591
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Recovery of varicella-zoster virus-specific T cell immunity after T cell-depleted allogeneic transplantation requires symptomatic virus reactivation.
    Distler E, Schnürer E, Wagner E, von Auer C, Plachter B, Wehler D, Huber C, Kolbe K, Meyer RG, Herr W.
    Biol Blood Marrow Transplant; 2008 Dec 01; 14(12):1417-24. PubMed ID: 19041065
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A live varicella vaccine in a pediatric community.
    Yabuuchi H, Baba K, Tsuda N, Okada S, Nose O, Seino Y, Tomita K, Ha K, Mimaki T, Ogawa M.
    Biken J; 1984 Sep 01; 27(2-3):43-9. PubMed ID: 6100057
    [Abstract] [Full Text] [Related]

  • 18. Identification of CD8+ T cell epitopes in the immediate early 62 protein (IE62) of varicella-zoster virus, and evaluation of frequency of CD8+ T cell response to IE62, by use of IE62 peptides after varicella vaccination.
    Frey CR, Sharp MA, Min AS, Schmid DS, Loparev V, Arvin AM.
    J Infect Dis; 2003 Jul 01; 188(1):40-52. PubMed ID: 12825169
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.